Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | USP2 | O75604 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | PPARG | P37231 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.72 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.72 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.66 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.60 |
| ▸ | APLNR | P35414 | 3/20 | 0.58 |
| ▸ | AVPR2 | P30518 | 2/20 | 0.56 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.55 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12311495 | 0.90 | MEN1 (0.66) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL15377173 | 0.90 | MEN1 (0.75) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL838533 | 0.90 | MEN1 (0.68) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL29674723 | 0.88 | MEN1 (0.79) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL30063035 | 0.88 | MEN1 (0.79) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL15376849 | 0.88 | MEN1 (0.67) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL30064677 | 0.88 | MEN1 (0.63) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL14351071 | 0.87 | MEN1 (0.68) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL13232606 | 0.87 | MEN1 (0.68) | MEN1USP2POLBPPARGBLM | |
| Hydrochloric Acid SCHEMBL19125055 | 0.87 | MEN1 (0.78) | MEN1USP2POLBPPARGBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107279-A1 | METHOD FOR ASSESSING VIABILITY OF MICROBIAL STRAINS | Kanvas Biosciences, Inc. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026102006-A1 | METHOD FOR IDENTIFYING MICROBIAL STRAINS | Kanvas Biosciences, Inc. (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026041049-A1 | METHOD FOR DETECTING PLURIPOTENT STEM CELLS BY MEANS OF HES3 DETECTION | 北京泽辉辰星生物科技有限公司 | 2026-02-26 | — | — | WO | claimed |
| US-20250387522-A1 | PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS | UNIV CASE WESTERN RESERVE (US) | 2025-12-25 | — | — | US | claimed |
| US-12410425-B2 | Highly multiplexed phylogenetic imaging of microbial communities | CORNELL UNIVERSITY (US) | 2025-09-09 | — | — | US | claimed |
| CN-119959556-A | ELISA kit for determining rFVIIa concentration in animal sample and detection method thereof | 成都蓉生药业有限责任公司 | 2025-05-09 | — | — | CN | claimed |
| CN-108139388-B | Particles comprising at least one ferrimagnetic or ferromagnetic iron oxide nanoparticle associated with at least one compound for medical or cosmetic use | 阿尔法医疗公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119959555-A | Detection kit for determining rFVIIa concentration in animal sample and detection method thereof | 成都蓉生药业有限责任公司 | 2025-05-09 | — | — | CN | claimed |
| US-20250093263-A1 | FRET-BASED ASSAYS | THE GENERAL HOSPITAL CORPORATION | 2025-03-20 | — | — | US | claimed |
| WO-2025054202-A1 | METHOD OF SCREENING A SAMPLE COMPRISING A TRANSGENE WITH A UNIQUE BARCODE | SANA BIOTECHNOLOGY, INC. (US) | 2025-03-13 | — | — | WO | claimed |
| EP-4158071-A1 | PROBE FOR THE DETECTION OF BACTERIAL INFECTIONS | Universita' Degli Studi di Udine (IT) | 2023-04-05 | — | — | EP | claimed |
| EP-4158057-A1 | MICROFLUIDIC METHOD FOR THE DETECTION OF NUCLEIC ACIDS | Disruptive Technological Advances In Life Science S.r.l. (IT) | 2023-04-05 | — | — | EP | claimed |
| WO-2023004438-A2 | FRET-BASED ASSAYS | THE GENERAL HOSPITAL CORPORATION (US) | 2023-01-26 | — | — | WO | claimed |
| WO-2022231334-A1 | METHOD FOR QUANTITATIVELY ANALYZING FLUORESCENT DYES LABELED ON EXTRACELLULAR VESICLE BY USING FLUORESCENCE CORRELATION SPECTROSCOPY, AND USE THEREOF | 재단법인 아산사회복지재단 | 2022-11-03 | — | — | WO | claimed |
| US-20220307070-A1 | METHOD | Stemnovate Limited (GB) | 2022-09-29 | — | — | US | claimed |
| EP-4038198-A1 | METHOD | Stemnovate Limited (GB) | 2022-08-10 | — | — | EP | claimed |
| US-11385235-B2 | DNA ink—near-field absorption coupling for colorimetric detection, DNA ink, chromic photoswitches, and chromic molecular ruler | BOISE STATE UNIVERSITY (US) | 2022-07-12 | — | — | US | claimed |
| US-20220193271-A1 | DETECTION OF COLONIC NEOPLASIA IN VIVO USING NEAR-INFRARED PEPTIDE TARGETED AGAINST OVEREXPRESSED CMET | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2022-06-23 | — | — | US | claimed |
| CN-114540466-A | miRNA-21 detection method and kit based on CRISPRCs 12a system | 重庆创芯生物科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| WO-2022076868-A1 | COMPOSITIONS, SYSTEMS, AND METHODS RELATED TO A DUAL-AFFINITY RATIOMETRIC QUENCHING BIOASSAY | NORTH CAROLINA STATE UNIVERSITY (US) | 2022-04-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387522-A1 | PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS | PSMA3, PSMA1, PSMA7 | MEN1 184/4885USP2 3435/4885POLB 1296/4885 |
| US-20250093263-A1 | FRET-BASED ASSAYS | TARBP1, GTPBP4, TERF2IP | MEN1 4133/4885USP2 2561/4885POLB 3783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.